TEDC2 has been identified as a potential oncogenic gene linked to immune infiltration in the tumor microenvironment in two recent studies focusing on hepatocellular carcinoma and laryngeal squamous cell carcinoma (35, 36). Here, TEDC2 is linked to laryngeal squamous cell carcinoma.